Temporal trajectory of quality of life and its predictors in recipients of hematopoietic stem cell transplantation

  • Ryul Kim
  • Kyung-Lak Son
  • Kwang-Min Lee
  • Younak Choi
  • Junshik Hong
  • Dong-Yeop Shin
  • Youngil Koh
  • Bong-Jin Hahm
  • Inho Kim
Original Article
  • 37 Downloads

Abstract

This prospective longitudinal study evaluated the temporal trajectory of health-related quality of life (HRQOL) and its associated factors in patients who received hematopoietic stem cell transplantation (SCT) 6 months after transplantation. Eighty-nine adult patients who were admitted to Seoul National University Hospital for SCT were consecutively included in the study. The participants completed three standardized questionnaires: Insomnia Severity Index, Hospital Anxiety and Depression Scale, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire. The participants completed the study questionnaires at three time points: before SCT (T1), immediately after SCT (T1), and 6 months after SCT (T3). Immediately after SCT, HRQOL decreased significantly (p < 0.001), followed by recovery over 6 months. The conditioning regimen for SCT showed no correlation with HRQOL at T2 (p = 0.283) or T3 (p = 0.799), with no significant difference in HRQOL between allogeneic and autologous SCT recipients at T2 (p = 0.829) or T3 (p = 0.824). Depression (p = 0.042), pain (p = 0.023), and appetite loss (p = 0.004) negatively influenced HRQOL at T1, whereas only pain (p = 0.048) remained an important factor at T2. Six months after SCT, the two most frequent symptoms, fatigue and financial problems, became major factors (p = 0.004 and p = 0.005, respectively). Depression began to play an important role in HRQOL again at T3 (p = 0.040). These findings demonstrate that SCT recipients need both psychological and medical support to achieve a better HRQOL after SCT.

Keywords

Stem cell transplantation Quality of life Supportive care Distress 

Notes

Acknowledgements

We thank our database manager, Mijin Yoon, for her accurate data management and BioMed Proofreading LLC for English editing. This work was supported by grants from the Seoul National University Hospital Research Fund (no. 0420160240) and Seoul National University College of Medicine (no. 800-20140171 to I.K.).

Authors’ contributions

R.K. contributed substantially to the manuscript by conceiving and constructing the analytical project, interpreting the data, and writing the first draft of the manuscript. R.K., Y.C., Y.K., B.J.H., and I.K. designed the study. J.H., D.Y.S., Y.K., B.J.H., and I.K. recruited the patients and analyzed the data. R.K., K.L.S., K.M.L., B.J.H., and I.K. contributed to the data analysis and interpretation and read, edited, and approved the final manuscript. All of the authors reviewed and approved the initial and final versions of the manuscript.

Compliance with ethical standards

This protocol was approved by the Institutional Review Board at SNUH (IRB approval no. H-1005-043-318) and was conducted in accordance with Declaration of Helsinki provisions.

Conflicts of interest

The authors have no conflicts of interest to declare or other disclosures.

Supplementary material

277_2018_3319_MOESM1_ESM.docx (22 kb)
ESM 1 (DOCX 21.9 kb)
277_2018_3319_MOESM2_ESM.docx (20 kb)
ESM 2 (DOCX 20.2 kb)
277_2018_3319_MOESM3_ESM.docx (21 kb)
ESM 3 (DOCX 21.2 KB)

References

  1. 1.
    Fuji S, Loffler J, Savani BN, Einsele H, Kapp M (2016) Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 52:657–662.  https://doi.org/10.1038/bmt.2016.306 CrossRefPubMedGoogle Scholar
  2. 2.
    Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8(1):33–39PubMedGoogle Scholar
  3. 3.
    (1995) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med (1982) 41(10):1403–1409Google Scholar
  4. 4.
    Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A, Hocker P, Dieckmann K, Fischer G, Rosenmayr A, Linkesch W, Hinterberger W, Lechner K, Greinix HT (2002) Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 30(9):619–626.  https://doi.org/10.1038/sj.bmt.1703677 CrossRefPubMedGoogle Scholar
  5. 5.
    Hjermstad MJ, Kaasa S (1995) Quality of life in adult cancer patients treated with bone marrow transplantation--a review of the literature. Eur J Cancer (Oxford, England : 1990) 31a(2):163–173CrossRefGoogle Scholar
  6. 6.
    Neitzert CS, Ritvo P, Dancey J, Weiser K, Murray C, Avery J (1998) The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplant 22(5):409–422.  https://doi.org/10.1038/sj.bmt.1701358 CrossRefPubMedGoogle Scholar
  7. 7.
    Wingard JR (1998) Quality of life following bone marrow transplantation. Curr Opin Oncol 10(2):108–111CrossRefPubMedGoogle Scholar
  8. 8.
    Fashoyin-Aje LA, Martinez KA, Dy SM (2012) New patient-centered care standards from the commission on cancer: opportunities and challenges. J Support Oncol 10(3):107–111.  https://doi.org/10.1016/j.suponc.2011.12.002 CrossRefPubMedGoogle Scholar
  9. 9.
    Pandey M, Sarita GP, Devi N, Thomas BC, Hussain BM, Krishnan R (2006) Distress, anxiety, and depression in cancer patients undergoing chemotherapy. World J Surg Oncol 4:68–68.  https://doi.org/10.1186/1477-7819-4-68 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Massie MJ (2004) Prevalence of depression in patients with cancer. JNCI Monographs 2004(32):57–71.  https://doi.org/10.1093/jncimonographs/lgh014 CrossRefGoogle Scholar
  11. 11.
    Pillay B, Lee SJ, Katona L, Burney S, Avery S (2014) Psychosocial factors predicting survival after allogeneic stem cell transplant. Support Care Cancer 22(9):2547–2555.  https://doi.org/10.1007/s00520-014-2239-7 CrossRefPubMedGoogle Scholar
  12. 12.
    Trask PC, Paterson A, Riba M, Brines B, Griffith K, Parker P, Weick J, Steele P, Kyro K, Ferrara J (2002) Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant 29(11):917–925.  https://doi.org/10.1038/sj.bmt.1703557 CrossRefPubMedGoogle Scholar
  13. 13.
    Howell D, Olsen K (2011) Distress-the 6th vital sign. Curr Oncol (Toronto, Ont) 18(5):208–210Google Scholar
  14. 14.
    Larsen J, Nordstrom G, Ljungman P, Gardulf A (2007) Factors associated with poor general health after stem-cell transplantation. Support Care Cancer 15(7):849–857.  https://doi.org/10.1007/s00520-006-0200-0 CrossRefPubMedGoogle Scholar
  15. 15.
    Bevans MF, Marden S, Leidy NK, Soeken K, Cusack G, Rivera P, Mayberry H, Bishop MR, Childs R, Barrett AJ (2006) Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 38(2):101–109.  https://doi.org/10.1038/sj.bmt.1705406 CrossRefPubMedGoogle Scholar
  16. 16.
    Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004) A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 34(3):257–266.  https://doi.org/10.1038/sj.bmt.1704561 CrossRefPubMedGoogle Scholar
  17. 17.
    Hacker ED, Ferrans CE (2003) Quality of life immediately after peripheral blood stem cell transplantation. Cancer Nurs 26(4):312–322CrossRefPubMedGoogle Scholar
  18. 18.
    Braamse AM, Gerrits MM, van Meijel B, Visser O, van Oppen P, Boenink AD, Cuijpers P, Huijgens PC, Beekman AT, Dekker J (2012) Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplant 47(6):757–769.  https://doi.org/10.1038/bmt.2011.130 CrossRefPubMedGoogle Scholar
  19. 19.
    Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMedGoogle Scholar
  20. 20.
    AN FPM, Bjordal K, Groenvold M, Curran D, Bottomley A, on, Group botEQoL (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organisation for Research and Treatment of Cancer, BrusselsGoogle Scholar
  21. 21.
    Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMedGoogle Scholar
  22. 22.
    Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52(2):69–77CrossRefPubMedGoogle Scholar
  23. 23.
    Savard MH, Savard J, Simard S, Ivers H (2005) Empirical validation of the insomnia severity index in cancer patients. Psycho-Oncology 14(6):429–441.  https://doi.org/10.1002/pon.860 CrossRefPubMedGoogle Scholar
  24. 24.
    Rosch PJ (1994) Insomnia, psychological assessment and management, Charles M. Morin, Guilford Press, New York, 1993. No. of pages: 238. Price: $26.95. Stress Med 10(1):69–70.  https://doi.org/10.1002/smi.2460100113 Google Scholar
  25. 25.
    Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106(8):2912–2919.  https://doi.org/10.1182/blood-2005-05-2004 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Broers S, Kaptein AA, Le Cessie S, Fibbe W, Hengeveld MW (2000) Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study. J Psychosom Res 48(1):11–21CrossRefPubMedGoogle Scholar
  27. 27.
    Fife BL, Huster GA, Cornetta KG, Kennedy VN, Akard LP, Broun ER (2000) Longitudinal study of adaptation to the stress of bone marrow transplantation. J Clin Oncol 18(7):1539–1549.  https://doi.org/10.1200/jco.2000.18.7.1539 CrossRefPubMedGoogle Scholar
  28. 28.
    Lee SJ, Fairclough D, Parsons SK, Soiffer RJ, Fisher DC, Schlossman RL, Antin JH, Weeks JC (2001) Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol Off J Am Soc Clin Oncol 19(1):242–252.  https://doi.org/10.1200/jco.2001.19.1.242 CrossRefGoogle Scholar
  29. 29.
    Mumby PB, Hurley C, Samsi M, Thilges S, Parthasarathy M, Stiff PJ (2012) Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants. Bone Marrow Transplant 47(4):556–561.  https://doi.org/10.1038/bmt.2011.129 CrossRefPubMedGoogle Scholar
  30. 30.
    Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO (1995) Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 52(2):100–113CrossRefPubMedGoogle Scholar
  31. 31.
    Trijsburg RW, van Knippenberg FC, Rijpma SE (1992) Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 54(4):489–517CrossRefPubMedGoogle Scholar
  32. 32.
    Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309(13):1359–1367.  https://doi.org/10.1001/jama.2013.2813 CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Kerr CW, Drake J, Milch RA, Brazeau DA, Skretny JA, Brazeau GA, Donnelly JP (2012) Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manag 43(1):68–77.  https://doi.org/10.1016/j.jpainsymman.2011.03.026 CrossRefGoogle Scholar
  34. 34.
    Association AP (2013) Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). American Psychiatric Publishing, ArlingtonCrossRefGoogle Scholar
  35. 35.
    Larsen J, Nordstrom G, Ljungman P, Gardulf A (2004) Symptom occurrence, symptom intensity, and symptom distress in patients undergoing high-dose chemotherapy with stem-cell transplantation. Cancer Nurs 27(1):55–64CrossRefPubMedGoogle Scholar
  36. 36.
    Hendriks MG, Schouten HC (2002) Quality of life after stem cell transplantation: a patient, partner and physician perspective. Eur J Int Med 13(1):52–56CrossRefGoogle Scholar
  37. 37.
    Larsen J, Gardulf A, Nordstrom G, Bjorkstrand B, Ljungman P (1996) Health-related quality of life in women with breast cancer undergoing autologous stem-cell transplantation. Cancer Nurs 19(5):368–375CrossRefPubMedGoogle Scholar
  38. 38.
    McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, Hurd DD (1997) Quality of life measurement in bone marrow transplantation: development of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) scale. Bone Marrow Transplant 19(4):357–368.  https://doi.org/10.1038/sj.bmt.1700672 CrossRefPubMedGoogle Scholar
  39. 39.
    McQuellon RP, Russell GB, Rambo TD, Craven BL, Radford J, Perry JJ, Cruz J, Hurd DD (1998) Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year. Bone Marrow Transplant 21(5):477–486.  https://doi.org/10.1038/sj.bmt.1701115 CrossRefPubMedGoogle Scholar
  40. 40.
    Fiuza-Luces C, Simpson RJ, Ramírez M, Lucia A, Berger NA (2016) Physical function and quality of life in patients with chronic graft-versus-host-disease: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients. Bone Marrow Transplant 51(1):13–26.  https://doi.org/10.1038/bmt.2015.195 CrossRefPubMedGoogle Scholar
  41. 41.
    Schwartz CE, Andresen EM, Nosek MA, Krahn GL (2007) Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil 88(4):529–536.  https://doi.org/10.1016/j.apmr.2006.12.032 CrossRefPubMedGoogle Scholar
  42. 42.
    Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S (1999) Hodgkin’s disease survivors more fatigued than the general population. J Clin Oncol Off J Am Soc Clin Oncol 17(1):253–261.  https://doi.org/10.1200/jco.1999.17.1.253 CrossRefGoogle Scholar
  43. 43.
    Leigh S, Wilson KC, Burns R, Clark RE (1995) Psychosocial morbidity in bone marrow transplant recipients: a prospective study. Bone Marrow Transplant 16(5):635–640PubMedGoogle Scholar
  44. 44.
    Molassiotis A, van den Akker OB, Milligan DW, Goldman JM, Boughton BJ, Holmes JA, Thomas S (1996) Quality of life in long-term survivors of marrow transplantation: comparison with a matched group receiving maintenance chemotherapy. Bone Marrow Transplant 17(2):249–258PubMedGoogle Scholar
  45. 45.
    Prieto JM, Saez R, Carreras E, Atala J, Sierra J, Rovira M, Batlle M, Blanch J, Escobar R, Vieta E, Gomez E, Rozman C, Cirera E (1996) Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant 17(6):1133–1142PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Ryul Kim
    • 1
  • Kyung-Lak Son
    • 2
  • Kwang-Min Lee
    • 3
    • 4
  • Younak Choi
    • 1
  • Junshik Hong
    • 1
  • Dong-Yeop Shin
    • 1
  • Youngil Koh
    • 1
  • Bong-Jin Hahm
    • 2
  • Inho Kim
    • 1
    • 5
  1. 1.Department of Internal MedicineSeoul National University HospitalSeoulSouth Korea
  2. 2.Department of NeuropsychiatrySeoul National University HospitalSeoulSouth Korea
  3. 3.Public Health Medical ServiceSeoul National University HospitalSeoulSouth Korea
  4. 4.Department of PsychiatryGyeonggi Provincial Medical Center Uijeongbu HospitalUijeongbuSouth Korea
  5. 5.Cancer Research InstituteSeoul National University College of MedicineSeoulSouth Korea

Personalised recommendations